Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.

CONCLUSION: The results underscore the important role of both PASI response and reduction in symptoms on improvements in health-related quality of life and work and daily activity in favour of secukinumab vs. ustekinumab. This article is protected by copyright. All rights reserved. PMID: 29355896 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29355896?dopt=Abstract

Source: The British Journal of Dermatology - January 21, 2018 Category: Dermatology Authors: Stull DE, Griffiths CEM, Gilloteau I, Zhao Y, Guana A, Finlay AY, Sherif B, Houghton K, Puig L Tags: Br J Dermatol Source Type: research